Surgical Robotics Technology

ReGen Scientific Introduces Synaptive Medical’s Evry™ in Canada


ReGen Scientific is a leader in personalized, preventative, and regenerative health.

ReGen Scientific has today announced it will become the first comprehensive health clinic in Canada to bring Synaptive Medical’s Evry™, a superconducting 0.5T head magnetic resonance imaging (MRI) system intended to provide MRI directly at the point-of-care, to their downtown Toronto location.

“Maintaining a healthy brain during one’s life is the uppermost goal in pursuing health and longevity,” said Dr. Robert Francis, chairman and co-founder of ReGen Scientific. “The information and images provided by Evry will inform and support our team of medical professionals in developing personalized proactive strategies to maintain and or restore brain health and cognitive performance to improve quality of life.”

At the heart of ReGen Scientific’s mission is to change the way health is measured and care is delivered with a hyper-personalized approach to health and wellness. “With ReGen Scientific’s adoption of Evry, for the first time ever, high performance MRI technology will become accessible directly at a patient’s point of care within a health clinic, giving doctors vital – and potentially life-saving – information when and where they need it most,” said Cameron Piron, president and co-founder of Synaptive Medical. “Our team spent years developing Evry and we are excited to partner with an already established Canadian leader in preventative health, ReGen Scientific, to bring this technology to Canadians seeking to understand the health of their brain well before issues arise.”

Evry, which received Health Canada approval in February 2020 and FDA clearance in April of 2020, is currently being used in connection with multiple research studies being done at the QEII Health Sciences Centre in Halifax, Nova Scotia including neuroimaging of stroke and tumor patients, with research funding also having been received to assess and track the impact that COVID-19 may have on the brain.

There are increasing scientific studies revealing that recovery from COVID-19 is a ‘long-haul’, meaning survivors continue to suffer debilitating illness and symptoms months after having it. This has created a COVID-19 ‘long-haulers’ global patient movement seeking help with understanding what has happened within their bodies.

Jean-Marc MacKenzie, CEO and co-founder of ReGen Scientific indicated, “ReGen Scientific is looking forward to supporting critical medical research on COVID-19 ‘long-haulers’, but more importantly, working to identify treatments that will assist individuals overcome with any lingering effects of COVID-19.”

Surgical Robotics Technology

Join thousands of Surgical Robotics Experts and get the latest updates straight to your inbox!